Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Myrick

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
American Journal of Clinical Pathology|January 1, 1993
Evaluation of the Coulter STKS five-part differentialP J Cornbleet, D Myrick, R Levy
American Journal of Clinical Pathology|December 1, 1992
Evaluation of the CELL-DYN 3000 differentialP J Cornbleet, D Myrick, S Judkins, et al.
Cancer Chemotherapy and Pharmacology|September 6, 2000
Combined cytotoxic action of paclitaxel and ceramide against the human Tu138 head and neck squamous carcinoma cell lineS Mehta, D Blackinton, I Omar, et al.
Leukemia Research|June 22, 1999
Paclitaxel-induced apoptosis in Jurkat, a leukemic T cell line, is enhanced by ceramideD Myrick, D Blackinton, J Klostergaard, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
American Journal of Clinical Pathology|January 1, 1993
Evaluation of the Coulter STKS five-part differentialP J Cornbleet, D Myrick, R Levy
American Journal of Clinical Pathology|December 1, 1992
Evaluation of the CELL-DYN 3000 differentialP J Cornbleet, D Myrick, S Judkins, et al.
Cancer Chemotherapy and Pharmacology|September 6, 2000
Combined cytotoxic action of paclitaxel and ceramide against the human Tu138 head and neck squamous carcinoma cell lineS Mehta, D Blackinton, I Omar, et al.
Leukemia Research|June 22, 1999
Paclitaxel-induced apoptosis in Jurkat, a leukemic T cell line, is enhanced by ceramideD Myrick, D Blackinton, J Klostergaard, et al.
Pageof 1